Order Article Reprints

Zijlstra JM, Follows G, Casasnovas R-O, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz FDl, et al. The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers. 2022; 14(3):791. https://doi.org/10.3390/cancers14030791

Zijlstra, Josée M., George Follows, Rene-Olivier Casasnovas, Joost S. P. Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, and et al. 2022. "The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study" Cancers 14, no. 3: 791. https://doi.org/10.3390/cancers14030791

Zijlstra, J. M., Follows, G., Casasnovas, R. -O., Vermaat, J. S. P., Kalakonda, N., Choquet, S., Hill, B., Thieblemont, C., Cavallo, F., Cruz, F. D. l., Kuruvilla, J., Hamad, N., Jaeger, U., Caimi, P., Gurion, R., Warzocha, K., Bakhshi, S., Sancho, J. -M., Schuster, M., ... Maerevoet, M. (2022). The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers, 14(3), 791. https://doi.org/10.3390/cancers14030791